Artículos por temáticas

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer's disease: a pilot study

Jelcic N, Agostini M, Meneghello F, Bussè C, Parise S, Galano A, Tonin P, Dam M, Cagnin A.

Clin Interv Aging. 2014 Sep 24;9:1605-11. doi: 10.2147/CIA.S68145. eCollection 2014.

The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers

Ayutyanont N, Langbaum JB, Hendrix SB, Chen K, Fleisher AS, Friesenhahn M, Ward M, Aguirre C, Acosta-Baena N, Madrigal L, Muñoz C, Tirado V, Moreno S, Tariot PN, Lopera F, Reiman EM.

J Clin Psychiatry. 2014 Jun;75(6):652-60. doi: 10.4088/JCP.13m08927.

Intranasal therapeutic strategies for management of Alzheimer's disease

Sood S, Jain K, Gowthamarajan K.

J Drug Target. 2014 May;22(4):279-94. doi: 10.3109/1061186X.2013.876644. Epub 2014 Jan 9.

An update on drug treatment options of Alzheimer's disease

Allgaier M, Allgaier C.

Front Biosci (Landmark Ed). 2014 Jun 1;19(8):1345-54. doi: 10.2741/4285.

FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease

Paroni G, Seripa D, Fontana A, D'Onofrio G, Gravina C, Urbano M, Cascavilla L, Pellegrini F, Greco A, Pilotto A.

Clin Interv Aging. 2014 Oct 21;9:1783-91. doi: 10.2147/CIA.S64758. eCollection 2014.

A multicenter, double-blind, placebo-controlled trial of the PDE9A inhibitor, PF-04447943, in Alzheimer's disease

Schwam EM, Nicholas T, Chew R, Billing CB, Davidson W, Ambrose D, Altstiel LD.

Curr Alzheimer Res. 2014;11(5):413-21. doi: 10.2174/1567205011666140505100858.

Harnessing the immune system for treatment and detection of tau pathology

Congdon EE, Krishnaswamy S, Sigurdsson EM.

J Alzheimers Dis. 2014;40 Suppl 1(0):S113-21. doi: 10.3233/JAD-132435.

SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs)

Kuduk SD, Beshore DC.

Curr Top Med Chem. 2014;14(15):1738-54. doi: 10.2174/1568026614666140826120224.

Efficacy of musical interventions in dementia: evidence from a randomized controlled trial

Narme P, Clément S, Ehrlé N, Schiaratura L, Vachez S, Courtaigne B, Munsch F, Samson S.

J Alzheimers Dis. 2014;38(2):359-69. doi: 10.3233/JAD-130893.

Patents on potential drugs to treat Alzheimer's disease: special emphasis on small peptides

Sundaram P, Nambiar AK, Sundaram RK.

Recent Pat CNS Drug Discov. 2014;9(2):71-5. doi: 10.2174/1574889809666140919123006.

A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease

Rafii MS, Baumann TL, Bakay RA, Ostrove JM, Siffert J, Fleisher AS, Herzog CD, Barba D, Pay M, Salmon DP, Chu Y, Kordower JH, Bishop K, Keator D, Potkin S, Bartus RT.

Alzheimers Dement. 2014 Sep;10(5):571-81. doi: 10.1016/j.jalz.2013.09.004. Epub 2014 Jan 7.

Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes. Update 2014

Froestl W, Muhs A, Pfeifer A.

J Alzheimers Dis. 2014;42(1):1-68. doi: 10.3233/JAD-140402.

Role of complement systems in IVIG mediated attenuation of cognitive deterioration in Alzheimer's disease

Gong B, Levine S, Barnum SR, Pasinetti GM.

Curr Alzheimer Res. 2014;11(7):637-44. doi: 10.2174/1567205011666140812113707.

Omega-3 fatty acids: a growing ocean of choices

Fares H, Lavie CJ, DiNicolantonio JJ, O'Keefe JH, Milani RV.

Curr Atheroscler Rep. 2014 Feb;16(2):389. doi: 10.1007/s11883-013-0389-6.

[Acetylcholinesterase inhibitors for treatment of Alzheimer's disease]

Shinagawa S, Shigeta M.

Brain Nerve. 2014 May;66(5):507-16.